MiMedx Group Inc
NASDAQ:MDXG

Watchlist Manager
MiMedx Group Inc Logo
MiMedx Group Inc
NASDAQ:MDXG
Watchlist
Price: 8.95 USD 19.81%
Market Cap: 1.3B USD
Have any thoughts about
MiMedx Group Inc?
Write Note

Relative Value

The Relative Value of one MDXG stock under the Base Case scenario is 7.06 USD. Compared to the current market price of 8.95 USD, MiMedx Group Inc is Overvalued by 21%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MDXG Relative Value
Base Case
7.06 USD
Overvaluation 21%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
22
vs Industry
73
Median 3Y
2.6
Median 5Y
2.6
Industry
8.1
Forward
3.7
vs History
9
vs Industry
8
Median 3Y
-13.9
Median 5Y
-14.2
Industry
23
Forward
29.1
vs History
19
vs Industry
6
Median 3Y
-24.6
Median 5Y
-24.6
Industry
23.4
vs History
14
vs Industry
1
Median 3Y
-29.7
Median 5Y
-20
Industry
27.3
vs History
66
vs Industry
13
Median 3Y
6.1
Median 5Y
8.1
Industry
2.6
vs History
25
vs Industry
63
Median 3Y
2.4
Median 5Y
2.5
Industry
8.1
Forward
3.5
vs History
25
vs Industry
61
Median 3Y
2.9
Median 5Y
3.1
Industry
9.6
vs History
50
vs Industry
7
Median 3Y
14.5
Median 5Y
15.6
Industry
4.3
Forward
17.6
vs History
49
vs Industry
7
Median 3Y
14.9
Median 5Y
16.1
Industry
3.8
Forward
21.2
vs History
19
vs Industry
6
Median 3Y
-23.6
Median 5Y
-23.6
Industry
6
vs History
19
vs Industry
5
Median 3Y
-20.7
Median 5Y
-20.7
Industry
3.8
vs History
44
vs Industry
28
Median 3Y
6.2
Median 5Y
6.8
Industry
4.8

Multiples Across Competitors

MDXG Competitors Multiples
MiMedx Group Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
MiMedx Group Inc
NASDAQ:MDXG
1.3B USD 3.8 16 18.3 19.4
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 563 478.2 -178 533.6 -216 796.7 -214 322.8
US
Abbvie Inc
NYSE:ABBV
300.2B USD 5.4 59 14.8 22.8
US
Amgen Inc
NASDAQ:AMGN
159.1B USD 4.9 37.4 17.5 33.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.6B USD 11.9 -263.9 26.7 28
US
Gilead Sciences Inc
NASDAQ:GILD
114.6B USD 4.1 910.1 10.1 10.1
US
Epizyme Inc
F:EPE
94.1B EUR 1 875.5 -478.6 -521.2 -507.3
AU
CSL Ltd
ASX:CSL
137.3B AUD 6 33.7 20.8 25.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
87.6B USD 6.3 18.8 17.3 19.2
US
Seagen Inc
F:SGT
39.3B EUR 18.1 -55.4 -59.5 -53.7
NL
argenx SE
XBRU:ARGX
34.1B EUR 18.5 -129.9 -104.5 -76.1
P/E Multiple
Earnings Growth
US
MiMedx Group Inc
NASDAQ:MDXG
Average P/E: 179.2
16
40%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -178 533.6 N/A
US
Abbvie Inc
NYSE:ABBV
59
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -263.9
42%
US
Gilead Sciences Inc
NASDAQ:GILD
910.1
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -478.6 N/A
AU
CSL Ltd
ASX:CSL
33.7
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.4 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
US
MiMedx Group Inc
NASDAQ:MDXG
Average EV/EBITDA: 17.9
18.3
150%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 796.7 N/A
US
Abbvie Inc
NYSE:ABBV
14.8
28%
US
Amgen Inc
NASDAQ:AMGN
17.5
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.7
38%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -521.2 N/A
AU
CSL Ltd
ASX:CSL
20.8
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.3
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.5 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
US
MiMedx Group Inc
NASDAQ:MDXG
Average EV/EBIT: 22.6
19.4
109%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -214 322.8 N/A
US
Abbvie Inc
NYSE:ABBV
22.8
88%
US
Amgen Inc
NASDAQ:AMGN
33.2
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -507.3 N/A
AU
CSL Ltd
ASX:CSL
25.9
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.2
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.1 N/A

See Also

Discover More
Back to Top